A DIVISION OF GENESIS CLINICAL DIAGNOSTICS

Live / Registered — Registered (as of 16 Aug 2022)

What this means for you

Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Aug 2028: the §8 declaration of use).

Record

Serial number
88246783
Registration number
6821397
Mark type
Design + words
Filed
02 Jan 2019
Published for opposition
10 Nov 2020
Registered
16 Aug 2022
Next maintenance filing
§8 declaration of use, due by 16 Aug 2028 (grace period to 16 Feb 2029)
Attorney of record
Christina E. Brule

Goods and services

  • Class 044 — Medical, beauty and agricultural services: Medical diagnostic testing, namely, infectious disease diagnosis through molecular based polymerase chain reaction testing for viral, fungal and bacterial infections, genetic testing by DNA analysis to detect gene mutations associated with the inherited susceptibility to cancer and to identify gene variants to predict the efficacy of certain drugs in a patient to treat a patient's disease or condition

Owner

Board proceedings on this mark

  • Opposition No. 91266093 — Abira Medical Laboratories LLC DBA Genesis Diagnostics LLC v. Medical Diagnostic Laboratories, LLC, filed 23 Nov 2020 (Terminated)
  • Ex Parte Appeal No. 88246783 — Medical Diagnostic Laboratories, LLC, filed 15 Sept 2020 (Terminated)

Prosecution history

  • 15 Sept 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 15 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 15 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 15 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
  • 12 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 10 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 30 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
  • 10 Jun 2022 — USE AMENDMENT FILED
  • 30 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 10 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
  • 28 Jan 2022 — ASSIGNED TO EXAMINER
  • 28 Dec 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 16 Nov 2021 — TTAB RELEASE CASE TO TRADEMARKS

View this trademark record on Rightsy